| HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition M Vaccari, S Fourati, SN Gordon, DR Brown, M Bissa, L Schifanella, ... Nature medicine 24 (6), 847-856, 2018 | 67 | 2018 |
| Human T cell leukemia virus type 1 infection of the three monocyte subsets contributes to viral burden in humans MF de Castro-Amarante, CA Pise-Masison, K McKinnon, ... Journal of virology 90 (5), 2195-2207, 2016 | 57 | 2016 |
| Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML) M Omsland, Ø Bruserud, BT Gjertsen, V Andresen Oncotarget 8 (5), 7946, 2017 | 55 | 2017 |
| Inhibition of tunneling nanotube (TNT) formation and human T-cell leukemia virus type 1 (HTLV-1) transmission by cytarabine M Omsland, C Pise-Masison, D Fujikawa, V Galli, C Fenizia, RW Parks, ... Scientific Reports 8 (1), 11118, 2018 | 54 | 2018 |
| Tunneling nanotube (TNT) formation is independent of p53 expression V Andresen, X Wang, S Ghimire, M Omsland, BT Gjertsen, HH Gerdes Cell Death & Differentiation 20 (8), 1124-1124, 2013 | 33 | 2013 |
| p30 protein: a critical regulator of HTLV-1 viral latency and host immunity R Moles, S Sarkis, V Galli, M Omsland, DFJ Purcell, D Yurick, G Khoury, ... Retrovirology 16, 1-15, 2019 | 22 | 2019 |
| Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice V Galli, CC Nixon, N Strbo, M Artesi, MF de Castro-Amarante, K McKinnon, ... Journal of virology 93 (19), 10.1128/jvi. 00565-19, 2019 | 22 | 2019 |
| INTERFERON ALPHA AND TYROSINE KINASE INHIBITORS INCREASE TUNNELING NANOTUBES (TNT) FORMATION AND CELL ADHESION IN CHRONIC MYELIOD LEUKEMIA (CML) CELL LINES M Omsland, V Andresen, SE Gullaksen, P Ayuda-Durán, M Popa, ... FASEB journal: official publication of the Federation of American Societies …, 2020 | 17 | 2020 |
| NK cells and monocytes modulate primary HTLV-1 infection R Moles, S Sarkis, V Galli, M Omsland, M Artesi, M Bissa, K McKinnon, ... PLoS Pathogens 18 (4), e1010416, 2022 | 15 | 2022 |
| Functional properties and sequence variation of HTLV-1 p13 M Omsland, M Silic-Benussi, R Moles, S Sarkis, DFJ Purcell, D Yurick, ... Retrovirology 17, 1-12, 2020 | 10 | 2020 |
| Intradermal vaccination with vididencel in MRD+ AML-patients leads to increase in antigen presenting cells and T-cells to the injection site, visualized using imaging mass … O Sefland, RK Kopperud, H Van Zeeburg, J Rovers, M Omsland, ... Blood 142, 2942, 2023 | | 2023 |
| The effect of chemotherapeutics on cell-to-cell transport of HTLV-1 and the p8 protein through membrane nanotubes M Omsland, C Pise-Masison, BT Gjertsen, G Franchini, V Andresen Retrovirology 12, 1-1, 2015 | | 2015 |
| CELL-TO-CELL COMMUNICATION IN ACUTE MYELOID LEUKEMIA BY TUNNELING NANOTUBES M Omsland, O Bruserud, BT Gjertsen, V Andresen HAEMATOLOGICA 99, 295-295, 2014 | | 2014 |
| Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease Ø Sefland, SE Gullaksen, M Omsland, H Reikvam, E Galteland, HTT Tran, ... Cytometry Part B: Clinical Cytometry, 0 | | |
